Physician profile
Michael D Cothran
NPI 1699249979
$404.15
in general payments reported to CMS, 2019-2025
10 companies · $79.07 in 2025
The $79.07 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.46 · 2022: $108 · 2023: $53.72 · 2024: $98.20 · 2025: $79.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $99.07 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $72.26 | 2022 | |
| Silk Road Medical, INC. | $48.03 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Bayer Healthcare Pharmaceuticals INC. | $46.42 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.90 | 2021 | |
| Gilead Sciences, INC. | $22.56 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.52 | 2024 | Lifevest |
| Melinta Therapeutics, LLC | $18.74 | 2023 | Kimyrsa, Vabomere |
| Abbvie INC. | $16.89 | 2025 | |
| Dexcom, INC. | $15.76 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cothran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.